0001562180-22-004174.txt : 20220518 0001562180-22-004174.hdr.sgml : 20220518 20220518083458 ACCESSION NUMBER: 0001562180-22-004174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glanzman Robert CENTRAL INDEX KEY: 0001835428 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39834 FILM NUMBER: 22937137 MAIL ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE STREET 2: SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clene Inc. CENTRAL INDEX KEY: 0001822791 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 852828339 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-676-9695 MAIL ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: Chelsea Worldwide Inc. DATE OF NAME CHANGE: 20200827 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-05-16 false 0001822791 Clene Inc. CLNN 0001835428 Glanzman Robert 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121 false true false false Chief Medical Officer Common Stock 2022-05-16 4 S false 4717.00 2.03 D 10564.00 D The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman. /s/ Jerry Miraglia POA 2022-05-18